Can I Use My HSA or FSA Account to Pay for My Calibrate Membership?

What the IRS Actually Says About Weight-Loss Programs

The IRS does not publish a yes-or-no list for every health product or service. It publishes a framework. IRS Publication 502 (2024) states that medical expenses are "the costs of diagnosis, cure, mitigation, treatment, or prevention of disease." Weight-loss programs qualify only when a physician prescribes them to treat a specific diagnosed condition such as obesity, hypertension, or type 2 diabetes. Programs undertaken simply to improve appearance or general fitness do not qualify.

The Disease-Treatment Standard

The phrase "treatment of a disease" carries real legal weight. The IRS has historically denied deductions for gym memberships and general diet programs because they serve a dual purpose: they benefit healthy people and sick people alike. A program passes the dual-purpose test when the primary purpose is medical rather than cosmetic or recreational.

Obesity was formally classified as a chronic disease by the American Medical Association in 2013. The CDC's current position is consistent with this: obesity is listed among the leading causes of preventable, chronic disease and disability in the United States (CDC, Overweight and Obesity). Because obesity carries its own ICD-10 diagnosis codes (E66.x), a clinician can document it as the condition being treated, which is exactly what the IRS standard requires.

Where Calibrate Fits

Calibrate markets itself as a physician-supervised metabolic health program that combines GLP-1 medication management with one-on-one health coaching across four domains: food, sleep, exercise, and emotional health. The physician component, including clinical evaluation, prescription management, and lab review, is the element most likely to satisfy the IRS "treatment of a disease" test. The coaching subscription portion is the gray zone.

Your plan administrator may split these two components differently. Some administrators will approve the medical-visit fees and the GLP-1 prescription copay but decline the membership or subscription fee. Others may approve the entire program if it is documented as an integrated treatment plan for a diagnosed condition.

How HSA and FSA Rules Differ in Practice

Both accounts let you pay for IRS-qualified medical expenses with pre-tax dollars, but the mechanics differ in ways that affect how you use them for a Calibrate membership.

HSA Rules

A Health Savings Account is available only to people enrolled in a High-Deductible Health Plan (HDHP). For 2025, the IRS set the minimum HDHP deductible at $1,650 for self-only coverage and $3,300 for family coverage, per IRS Rev. Proc. 2024-25. The 2025 HSA contribution limit is $4,300 for self-only and $8,550 for family.

HSA funds roll over indefinitely. You can pay for a Calibrate membership in 2025 with money contributed in 2022, provided you have documentation that you were HSA-eligible when the contribution was made. Withdrawals for non-qualified expenses before age 65 incur both income tax and a 20% penalty.

FSA Rules

A Flexible Spending Account is employer-sponsored and does not require HDHP enrollment. The 2025 contribution limit is $3,300 per IRS Rev. Proc. 2024-25. FSAs operate on a use-it-or-lose-it basis with a grace period or $660 rollover allowed at employer discretion. Because Calibrate memberships are typically billed annually or monthly on a recurring schedule, timing matters. You may need to submit your FSA claim within the plan year in which the expense occurred.

Which Account to Use First

If you have both an HSA and a limited-purpose or general FSA available, use the FSA first for predictable, recurring Calibrate charges, then preserve your HSA balance for expenses that arise outside the FSA plan year. This strategy minimizes the risk of FSA forfeiture.

GLP-1 Medications and HSA/FSA Eligibility

Prescription medications are unambiguously HSA/FSA eligible under IRS Publication 502. Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda) all require a prescription, so your out-of-pocket cost at the pharmacy, including any portion not covered by insurance, can be paid from your HSA or FSA without any additional documentation beyond the prescription itself.

Clinical Evidence Supporting GLP-1 Use for Obesity

The STEP-1 trial (N=1,961) demonstrated that semaglutide 2.4 mg subcutaneous injection once weekly produced 14.9% mean body weight loss at 68 weeks, compared with 2.4% in the placebo group (P<0.001) (Wilding et al., NEJM, 2021). This magnitude of weight reduction is clinically meaningful for cardiometabolic risk reduction.

The SURMOUNT-1 trial (N=2,539) showed that tirzepatide 15 mg produced a mean weight reduction of 20.9% at 72 weeks versus 3.1% placebo (P<0.001) (Jastreboff et al., NEJM, 2022). Both trials enrolled participants with a BMI of 30 or greater, or BMI of 27 or greater with at least one weight-related comorbidity. That enrollment threshold maps directly onto the IRS disease-treatment standard: these drugs are prescribed for a diagnosed chronic condition, not for cosmetic purposes.

What This Means for Your HSA/FSA Claim

If Calibrate prescribes you semaglutide or tirzepatide, that prescription cost is clearly eligible. Pay it from your HSA or FSA at the pharmacy. The membership fee that covers physician oversight and coaching is the portion requiring more documentation.

Letters of Medical Necessity: What to Include

A Letter of Medical Necessity (LMN) is a signed document from your treating clinician that explains why a specific treatment or service is medically required for your diagnosed condition. FSA and HSA administrators are not required by law to accept an LMN, but most major third-party administrators do, and many will reverse a denied claim when one is submitted.

A complete LMN for a Calibrate-related claim should include:

• Patient name and date of birth
• Clinician name, credentials, NPI number, and contact information
• ICD-10 diagnosis code (for example, E66.01 for morbid obesity due to excess calories)
• A statement that the Calibrate program is being prescribed as treatment for the documented diagnosis, not for cosmetic or general wellness purposes
• The expected duration of treatment (typically 12 months)
• A statement that the program is not available through a standard insurance benefit
• Clinician signature and date

Ask your Calibrate clinician for this letter before you submit your first HSA or FSA claim. Some plans require the LMN at the time of submission; others request it only if the claim is flagged.

What Plan Administrators Look For When They Review Claims

Your HSA custodian (typically a bank or financial institution) and your FSA administrator (typically a third-party benefits company) each set their own internal eligibility standards within IRS guidelines. The IRS sets the ceiling; your administrator may set a lower bar.

Common Reasons Claims Are Denied

• The merchant category code on your Calibrate charge does not match a recognized medical-expense category.
• The claim is submitted as a single bundled "membership fee" rather than itemized medical services.
• No diagnosis code or LMN accompanies the claim.
• The administrator categorizes the program as a general wellness benefit rather than a medical treatment.

Appealing a Denied Claim

Most FSA administrators have a formal appeals process. Submit your LMN, an itemized receipt showing what services were rendered (physician consultation, lab review, medication management), and a written explanation citing IRS Publication 502 and the CDC's classification of obesity as a chronic disease. If the appeal is denied at the administrator level, you may file a complaint with the Department of Labor's Employee Benefits Security Administration for FSA plans governed by ERISA.

Tax Documentation and Recordkeeping

The IRS recommends keeping records supporting HSA or FSA withdrawals for at least three years from the date you file the return on which the distribution appears. For a Calibrate membership paid across 12 months in 2025, keep:

• Itemized monthly or annual receipts from Calibrate
• A copy of your LMN signed by your clinician
• Your diagnosis documentation (lab results showing HbA1c, BMI measurement, lipid panel)
• Records showing the dates you were enrolled in an HDHP (for HSA claims)

The IRS Form 8889 is filed with your federal return each year you make HSA contributions or take distributions. Line 17a reports total distributions; line 17b reports qualified medical expenses. If your Calibrate expenses are questioned, your LMN and itemized receipts are your primary defense.

How Other Obesity-Medicine Guidelines View This Question

The Endocrine Society's 2015 Clinical Practice Guideline on Pharmacological Management of Obesity (Apovian et al., JCEM, 2015) states that pharmacotherapy for obesity is indicated for patients with a BMI of 30 or greater, or BMI of 27 or greater with an obesity-related comorbidity. The guideline further notes that weight-loss pharmacotherapy "should be used as an adjunct to, not as a replacement for, lifestyle modification." This language directly supports the argument that a combined medication-plus-coaching program like Calibrate is a single integrated medical treatment rather than two separate products.

The American Association of Clinical Endocrinology (AACE) 2016 Obesity Clinical Practice Guidelines (Garvey et al., Endocrine Practice, 2016) similarly recommend multicomponent treatment combining dietary modification, physical activity, behavioral intervention, and pharmacotherapy as the standard of care for chronic obesity management.

Citing these guidelines in your LMN strengthens your claim that the program follows accepted medical standards.

Practical Steps Before You Pay

Paying for a Calibrate membership impulsively from your HSA or FSA without preparation raises your denial risk. A systematic approach reduces it.

Step 1: Confirm Your Diagnosis

Before enrolling in Calibrate, ensure your chart contains an active obesity diagnosis with an ICD-10 code. Your primary care physician or the Calibrate clinical team can document this.

Step 2: Request Your LMN

Ask your clinician to draft the LMN using the components listed in the framework section above. Do this before your first charge clears.

Step 3: Contact Your Plan Administrator

Call the number on the back of your benefits card and ask specifically: "Does your plan cover physician-supervised obesity treatment programs billed as a membership fee, when accompanied by a Letter of Medical Necessity?" Document the representative's name, the date, and the answer.

Step 4: Submit with Full Documentation

When you submit the claim, attach the LMN and itemized receipt. Some administrators allow PDF attachments through an online portal; others require fax or mail.

Step 5: Keep Everything

Store digital copies of every document in a dedicated folder labeled by tax year. The IRS has up to three years to audit a return in most circumstances, and up to six years if it suspects substantial underreporting.

Specific Cost Scenarios

Understanding how costs break down helps you plan which portion to pay from which account.

Scenario A: Full Calibrate membership paid as a lump sum. This is the highest-risk scenario for denial because the charge appears as a single undifferentiated amount. Request an itemized invoice from Calibrate showing the physician consultation fee, lab fee, and coaching fee separately before submitting.

Scenario B: GLP-1 medication only, billed through pharmacy. This is the lowest-risk scenario. Prescription drug copays are clearly eligible. Pay directly from your HSA or FSA debit card at the pharmacy counter.

Scenario C: Monthly membership plus separate pharmacy copay. Submit the pharmacy charge with zero additional documentation. Submit the monthly membership charge with the LMN and itemized invoice.

Scenario D: Insurance covers part of the program. You may use HSA/FSA funds only for the out-of-pocket portion not reimbursed by insurance. Double-dipping, meaning claiming the same expense from insurance and an HSA/FSA, violates IRS rules and could result in penalties.

What Recent Coverage Expansions Mean for 2025 and Beyond

The Affordable Care Act requires most non-grandfathered health plans to cover obesity screening and counseling with no cost-sharing when delivered by a primary care clinician (USPSTF Grade B Recommendation, 2018). This means some components of obesity management may shift from HSA/FSA territory to direct insurance coverage, depending on how Calibrate's services are classified by your insurer.

GLP-1 medications for obesity, as distinct from diabetes, still lack universal insurance coverage. The STEP-5 trial (N=304) demonstrated sustained weight reduction of 15.2% over 104 weeks with semaglutide 2.4 mg weekly (Garvey et al., Obesity, 2022), reinforcing the long-term medical necessity argument that insurers and HSA/FSA administrators will increasingly face.

Until insurance coverage for GLP-1 obesity treatment becomes standard, HSA and FSA accounts remain the most accessible pre-tax payment mechanism for programs like Calibrate. For the 2025 plan year, confirm your HSA contribution was made before the April 15, 2026 tax-filing deadline to maximize your eligible pool of funds.